The alpha1-beta-subunit interaction that modulates calcium channel activity is reversible and requires a competent alpha-interaction domain.
High voltage-gated calcium channels consist of a pore-forming subunit (alpha(1)) and three nonhomologous subunits (alpha(2)/delta, beta, and gamma). Although it is well established that the beta-subunit promotes traffic of channels to the plasma membrane and modifies their activity, the reversible nature of the interaction with the alpha(1)-subunit remains controversial. Here, we address this issue by examining the effect of purified beta(2a) protein on Ca(V)1.2 and Ca(V)2.3 channels expressed in Xenopus oocytes. The beta(2a)-subunit binds to the alpha(1)-interaction domain (AID) in vitro, and when injected into oocytes, it shifts the voltage dependence of activation and increases charge movement to ionic current coupling of Ca(V)1.2 channels. This increase depended on the integrity of AID but was not abolished by bafilomycin, demonstrating that the alpha(1)-beta interaction through the AID site can take place at the plasma membrane. Furthermore, injection of beta(2a) protein inhibited inactivation of Ca(V)2.3 channels and converted fast inactivating Ca(V)2.3/beta(1b) channels to slow inactivating channels. Inhibition of inactivation required larger concentration of beta(2a) in oocytes expressing Ca(V)2.3/beta(1b) channels than expressing Ca(V)2.3 alone but reached the same maximal level as expected for a competitive interaction through a single binding site. Together, our data show that the alpha(1)-beta interaction is reversible in intact cells and defines calcium channels beta-subunits as regulatory proteins rather than stoichiometric subunits.
Hidalgo
Patricia
P
Abteilung Neurophysiologie, Medizinische Hochschule Hannover, 30625 Hannover, Germany.
Gonzalez-Gutierrez
Giovanni
G
Garcia-Olivares
Jennie
J
Neely
Alan
A
D000818:Animals; D001665:Binding Sites; D020746:Calcium Channels, L-Type / Q000737:chemistry* / Q000502:physiology; D020908:Calcium Channels, R-Type / Q000737:chemistry* / Q000502:physiology; D004594:Electrophysiology; D015640:Ion Channel Gating / Q000187:drug effects; D018942:Macrolides / Q000494:pharmacology; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D021122:Protein Subunits; D051381:Rats; D014364:Tryptophan; D014981:Xenopus
D020746:Calcium Channels, L-Type; D020908:Calcium Channels, R-Type; C419385:L-type calcium channel alpha(1C); D018942:Macrolides; D021122:Protein Subunits; D014364:Tryptophan